Development and Validation of a Nomogram for Predicting Overall Survival to Concurrent Chemoradiotherapy in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma

Figure 3

The calibration curve for predicting patient survival at (a) 3 years and (b) 5 years in the validation set.

(a)

(b)